Tuğba İZCİ DURAN, Seyyid Bilal AÇIKGÖZ, Cemal GÜRBÜZ, Ayşegül UÇAR, Gökhan Yavuz BİLGE, Metin ÖZGEN

İmmünsüpresif İlaç Kullanan Romatoloji Hastalarında COVID-19 Pandemisinin Anksiyete Üzerine Etkisi

Giriş: : Bu çalışmanın amacı, Coronavirus hastalığı-2019 (COVID-19) salgınının ilk aşamasında romatizmal ve kas-iskelet sistemi hastalıkları (RMDs) olan ve immunsupresif ilaç kullanan hastalarda COVID-19 salgınına bağlı anksiyete yaygınlığını tespit etmek ve anksiyeteye sebep olan risk ve koruyucu faktörleri tanımlamaktır. Yöntem: 18 yaşından büyük, RMDs’i olan ve düzenli immunsupresif ilaç kullanan 145 hasta ve 95 sağlıklı kontrol çalışmaya dahil edildi. COVID-19 salgını ile ilgili soruları içeren anonim bir anket ve katılımcıların anksiyete düzeylerini ölçmek için Beck anksiyete envanteri (BAI) kullanıldı. Demografik veriler, mevcut RMDs’i, kullandığı immunsupresif ilaç, COVID-19 hakkında bilgi ve endişeler, COVID-19 hakkındaki bilgileri nereden öğrendiği gibi ek bilgiler toplandı. Bulgular: Hastaların %42,1’i kullandıkları ilaç nedeniyle salgının endişe yarattığını bildirdi ve hastaların %33,8’i endişelerini orta ve şiddetli olarak derecelendirdiler. Hastaların BAI skorları 4 (0-52) ve sağlıklı kontrollerin BAI skorları 3 (0-18) olarak saptandı. BAI skorlarına göre hastaların %16,5’i orta ile şiddetli anksiyete belirtileri göstermiştir. İmmunsupresif ilaç kullanan hastaların %38,6’sında anksiyete saptanırken kontrol grubunun %18,9’unda anksiyete mevcuttu. Gruplar karşılaştırıldığında hasta grubunun anksiyetesi anlamlı yüksek saptandı (p=0.001). Hasta ve kontrol gruplarında kadın cinsiyet daha fazla anksiyete belirtileri göstermektedir (p

Effect of COVID-19 Pandemic on Anxiety in Rheumatology Patients Taking Immunosuppressive Drugs

Objective: The purpose of this study was to determine the prevalence of anxiety due to Coronavirus disease-2019 (COVID-19) pandemic in patients with rheumatic and musculoskeletal diseases (RMDs) who used immunosuppressive drugs during the initial stage of the COVID-19 pandemic and to identify the risk and protective factors that cause anxiety. Method: A total of 145 patients with RMDs who used regular immunosuppressive drugs and 95 healthy controls were included. An anonymous survey comprising questions regarding the COVID-19 pandemic was used, and the Beck anxiety inventory (BAI). Results: About 42.1% patients reported that the epidemic caused concern due to the drug they were using, 33.8% rated their concerns as moderate and severe. According to the BAI scores, 16.5% patients had moderate to severe anxiety symptoms; and comparison of the groups showed that the anxiety level of the patient group was significantly higher (38.6% vs. 18.9%, p=0.001). Female had more anxiety symptoms in both groups (p

PDF

___

1. Song J, Kang S, Choi SW, Seo KW, Lee S, So MW, et al. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs. Rheumatol Int. 2020;40(6):991-5.
2. Organization WH. Coronavirus disease 2019 (COVID-19) : situation report, 51. 2020.
3. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470-3.
4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.
5. Nishiura H, Kobayashi T, Yang Y, Hayashi K, Miyama T, Kinoshita R, et al. The rate of underascertainment of novel coronavirus (2019-nCoV) infection: Estimation using Japanese passengers data on evacuation flights. Multidisciplinary Digital Publishing Institute; 2020.
6. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. 2020.
7. Hall RC, Hall RC, Chapman MJ. The 1995 Kikwit Ebola outbreak: lessons hospitals and physicians can apply to future viral epidemics. Gen Hosp Psychiatry. 2008;30(5):446-52.
8. Peng EY, Lee MB, Tsai ST, Yang CC, Morisky DE, Tsai LT, et al. Population-based postcrisis psychological distress: an example from the SARS outbreak in Taiwan. J Formos Med Assoc. 2010;109(7):524-32.
9. Organization WH. Mental health and psychosocial considerations during the COVID-19 outbreak, 18 March 2020. World Health Organization; 2020.
10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.
11. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74.
12. Rubin GJ, Wessely S. The psychological effects of quarantining a city. Bmj. 2020;368.
13. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in china. International Journal of Environmental Research and Public Health. 2020;17(5):1729.
14. Rheumatism TELA. EULAR Guidance for patients COVID-19 outbreak 2020 https://www.eular.org/eular_guidance_for_ patients_covid19_outbreak.cfm.
15. Rubin GJ, Potts HW, Michie S. The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: resultsfrom 36 national telephone surveysin the UK. Health Technol Assess. 2010;14(34):183- 266.
16. Leung GM, Quah S, Ho LM, Ho SY, Hedley AJ, Lee HP, et al. Community psychobehavioural surveillance and related impact on outbreak control in Hong Kong and Singapore during the SARS epidemic. Hong Kong Med J. 2009;15 Suppl 9:30-4.
17. Ulusoy M, Sahin NH, Erkmen H. The Beck anxiety inventory: psychometric properties. Journal of cognitive psychotherapy. 1998;12(2):163-72.
18. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. Journal of consulting and clinical psychology. 1988;56(6):893.
19. Taylor S. The Psychology of Pandemics: Preparing for the Next Global Outbreak of Infectious Disease: Cambridge Scholars Publishing; 2019.
20. Taylor S, Asmundson GJ. Treating health anxiety: A cognitive-behavioral approach: Guilford Press; 2004.
21. Patel A, Jernigan DB. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(5):140-6.
22. Remes O, Brayne C, Van Der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and behavior. 2016;6(7):e00497.
23. Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43(2):476-93.
24. Zhang MW, Ho CS, Ho R. Methodology of development and students’ perceptions of a psychiatry educational smartphone application. Technology and Health Care. 2014;22(6):847- 55.
25. Do TTT, Le MD, Van Nguyen T, Tran BX, Le HT, Nguyen HD, et al. Receptiveness and preferences of health-related smartphone applications among Vietnamese youth and young adults. BMC Public Health. 2018;18(1):764.
26. Lisitsyna TA, Veltishchev DY, Seravina OF, Kovalevskaya OB, Starovoytova MN, Desinova OV, et al. Comparative analysis of anxietydepressive spectrum disorders in patients with rheumatic diseases. Ter Arkh. 2018;90(5):30-7.
27. Baysal O, Durmus B, Ersoy Y, Altay Z, Senel K, Nas K, et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int. 2011;31(6):795-800.
28. Isik A, Koca SS, Ozturk A, Mermi O. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol. 2007;26(6):872-8.
29. Xu X, Shen B, Zhang A, Liu J, Da Z, Liu H, et al. Anxiety and depression correlate with disease and quality-of-life parameters in Chinese patients with ankylosing spondylitis. Patient preference and adherence. 2016;10:879.
30. Yilmaz-Oner S, Oner C, Dogukan FM, Moses TF, Demir K, Tekayev N, et al. Anxiety and depression predict quality of life in Turkish patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2015;33(3):360-5.